Entereg Oral Capsule 12Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Entereg: Oral capsule (12mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ALVIMOPAN (AL vi MOE pan) is used to help the gut function after having gut surgery.

In-Depth Information
Select a Medication

Entereg 12mg Capsule

NDC: 112270010
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Ileus Prophylaxis

Sometimes used for but not FDA approved for the following conditions:
Opiate Agonist-induced Constipation

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Entereg 12mg Capsule

Reported Side Effects for Entereg 12mg Capsule

Gas Incidence:
3.1-8.7%*
Severity: MILD
Onset: EARLY
Retaining Urine Incidence:
3.2-3.5%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
3.4%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
4.0-9.7%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
5.2-5.4%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
5.9-7.0%*
Severity: MILD
Onset: EARLY
Low Potassium Levels Incidence:
6.9-9.5%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Entereg

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5